FR900359

4 Cited Publications
Customer Review

Based on 4 publication(s) in Google Scholar

FR900359 is a depsipeptide selective inhibitor of q/11/14 in mammalia, can inhibits ERK pathway. FR900359 suppresses the proliferation of melanoma cells and decreases of blood pressure. FR900359 also protected against airway hyperreactivity in murine models of allergen sensitization in Ovalbumin, low endotoxin (HY-W250978A)-induced sensitization model of asthma. FR900359 can be used for cancer and cardiovascular disease research.

For research use only. We do not sell to patients.

  • Purity: 99.90%
  • CAS No.: 107530-18-7
  • Formula: C49H75N7O15
  • Molecular Weight:1002.16
  • Storage:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Customer Validation & Images
WBBio/Physico-chemical Assay
  • WB
  • Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay

All ERK Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00